Cell Your Idea
In this episode, we’re joined by Pablo Hofbauer, co-founder of HeartBeat.bio and a leading innovator in self-organizing cardiac organoids, known as cardioids. Pablo shares his journey into biotechnology and explores how cardioids are transforming cardiac drug discovery. We discuss their applications in studying genetic mutations, the significant advantages they offer over traditional 2D models, and their potential to inform future therapies. Pablo also provides insights into the complex process of commercializing scientific research, covering topics from patent strategies to funding challenges. Additionally, he highlights the impact of AI and robotics in enhancing research at HeartBeat.bio. This episode offers an exciting insight into heart health and the evolving landscape of biotech innovation. Timestamps 00:00:49 Introduction to Pablo 00:02:45 What are cardioids? 00:03:59 The Role of Personalised Medicine 00:05:14 Mutations Studies using CRISPR Genetic Engineering 00:08:03 Traditional 2D models vs 3D models of the Heart Chamber 00:13:04 Cell therapy: Pig Heart Transplanted 00:15:06 Future Potential Therapies 00:17:52 Challenges in Commercialisation of Research 00:19:10 Intellectual Property - Patents 00:20:20 Securing funding - Scientific Pitching 00:21:55 Company Partnerships - Robotics 00:23:32 Hitting Milestones 00:26:03 Artificial Intelligence and Machine Learning 00:27:35 Advice for Aspiring Scientists 00:28:38 Fun Fact
4 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Cell Your Idea!